GlassScriptPhysician profile
Hugh Rollins Daniel
NPI 1821092636
$2,389.10
in general payments reported to CMS, 2019-2025
15 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,414 · 2020: $307 · 2021: $100 · 2022: $224 · 2023: $128 · 2024: $82.93 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,370.60 | 2019-2020 | |
| Integra Lifesciences Corporation | $221.59 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $193.41 | 2021-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $161.27 | 2019-2022 | |
| Smith+Nephew, INC. | $130.16 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Aroa Biosurgery Incorporated | $62.20 | 2019-2020 | |
| Ethicon US, LLC | $38.62 | 2021-2022 | |
| Abbvie INC. | $37.53 | 2023-2025 | Dalvance |
| Hologic Sales and Service, LLC | $35.65 | 2022 | |
| Allergan, INC. | $35.16 | 2019 | |
| Novo Nordisk INC | $29.48 | 2025 | Wegovy |
| Abbott Laboratories | $20.99 | 2025 | Perclose Prostyle |
| Boston Scientific Corporation | $20.61 | 2025 | General - Angioplasty |
| Ovik Health, LLC | $16.54 | 2019 | |
| Cook Medical LLC | $15.29 | 2024 | Zilver Ptx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.